You are here
Andrew Leuchter, M.D.
Dr. Leuchter is a Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA. He also is Director of the Neuromodulation Division and a Senior Research Scientist at the Semel Institute. Dr. Leuchter is a graduate of Stanford University and the Baylor College of Medicine who joined the UCLA faculty in 1986.
An internationally recognized expert on the treatment of mood disorders, Dr. Leuchter directs the Transcranial Magnetic Stimulation (TMS) Service, which performs more than 5,000 treatments each year for patients with depression, pain, and other neuropsychiatric illness. He is leading clinical trials to develop novel neuromodulation technologies for the treatment of depression and Post-Traumatic Stress Disorder (PTSD), including synchronized Transcranial Magnetic Stimulation (sTMS) and Trigeminal Nerve Stimulation (TNS). He also has unique expertise in the development of neurophysiologic biomarkers to inform diagnostic and treatment decisions. A Board-certified electroencephalographer, Dr. Leuchter has shown that changes in brain oscillations early in treatment can be used to select antidepressant treatments that are most likely to benefit an individual patient.
Dr. Leuchter has authored over 150 scientific articles on topics including neuromodulation for the treatment of depression, EEG biomarkers to guide treatment of neuropsychiatric illness, and theories of antidepressant action.